mizoribine has been researched along with Leukemia L5178 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furusawa, M; Inoue, K; Ishida, H; Ishiguro, M; Mori, N; Murakami, T; Oda, K; Okumi, M; Shuto, S; Tanabe, K; Unagami, K | 1 |
| Katsunuma, T; Kusumi, T; Tsuda, M; Yamamura, M | 1 |
2 other study(ies) available for mizoribine and Leukemia L5178
| Article | Year |
|---|---|
Uptake and metabolism of mizoribine, an immunosuppressant, in L5178Y-R mouse lymphoma cells in vitro and peripheral blood mononuclear cells of rats and kidney transplant recipients in vivo.
Topics: Adenosine; Administration, Oral; Animals; Immunosuppressive Agents; Kidney Transplantation; Leukemia L5178; Leukocytes, Mononuclear; Male; Mice; Mice, Inbred ICR; Rats; Rats, Sprague-Dawley; Ribonucleosides | 2018 |
Dual inhibitory effect of bredinin.
Topics: Animals; Antibiotics, Antineoplastic; Carcinoma 256, Walker; Growth Inhibitors; Leukemia L5178; Rats; Rats, Inbred Strains; Ribonucleosides | 1989 |